Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non–Small Cell Lung Cancer
JCO Clinical Cancer Informatics · 2025
DOI: 10.1200/cci-24-00315 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025. Verfasst von Brian D Gonzalez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ambulatory Care. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Patients receiving systemic therapy (ST) for non–small cell lung cancer (NSCLC) experience toxicities that negatively affect patient outcomes. This study aimed to test an approach for prospectively collecting patient-reported outcome (PRO) data, wearable sensor data (WSD), and clinical data, and develop a machine learning (ML) algorithm to predict health care utilization, specifically urgent care (UC) visits. MATERIALS AND METHODS Patients with NSCLC completed the PROMIS-57 PRO quality-of-life measure and wore a Fitbit to monitor patient-generated health data from ST initiation through day 60. Demographic and clinical data were abstracted from the medical record. ML explainable models on the basis of Bayesian Networks (BNs) were used to develop predictive models for UC visits. RESULTS Patients in the training data set (N = 58) were age 69 years on average (range, 35-89) and mostly female (57%), White (88%), and non-Hispanic (95%) patients with adenocarcinoma (69%). Initial BN models trained on demographic and clinical data demonstrated moderate predictive accuracy on cross-validation for UC visits before ST (AUC, 0.72 [95% CI, 0.57 to 0.80]) and during ST (AUC, 0.81 [95% CI, 0.63 to 0.89]). Incorporating PRO and WSD during ST yielded enhanced models with significantly improved performance (final AUC, 0.86 [95% CI, 0.76 to 0.95]) via DeLong test ( P < .001). CONCLUSION Multidimensional data sources, including demographic, clinical, PRO, and WSD, can enhance ML predictive models to elucidate complex, interactive factors influencing health care utilization during the first 60 days of ST. Use of explainable ML to predict and prevent treatment toxicities and health care utilization could improve patient outcomes and enhance the quality of cancer care delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.
- Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL.
- Department of Industrial and Management Systems Engineering, University of South Florida, Tampa, FL.
- Department of Machine Learning, Moffitt Cancer Center, Tampa, FL.
ORCID-Profile: Brian D Gonzalez, Xiaoyin Li, Lisa M Gudenkauf, Jerrin J Pullukkara, Aasha I Hoogland, Trung Le, Issam El Naqa, Andreas N Saltos
Förderung
- NCI NIH HHS
Zitieren
APA
Gonzalez, B. D., Li, X., Gudenkauf, L. M., Pullukkara, J. J., Oswald, L. B., Hoogland, A. I., Le, T., El Naqa, I., Saltos, A. N., Haura, E. B., & Luo, Y. (2025). Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non–Small Cell Lung Cancer. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-24-00315
Vancouver
Gonzalez BD, Li X, Gudenkauf LM, Pullukkara JJ, Oswald LB, Hoogland AI, et al. Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non–Small Cell Lung Cancer. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-24-00315
BibTeX
@article{Gonzalez2025,
author = {Gonzalez, Brian D and Li, Xiaoyin and Gudenkauf, Lisa M and Pullukkara, Jerrin J and Oswald, Laura B and Hoogland, Aasha I and Le, Trung and El Naqa, Issam and Saltos, Andreas N and Haura, Eric B and Luo, Yi},
title = {Using Bayesian Networks to Predict Urgent Care Visits in Patients Receiving Systemic Therapy for Non–Small Cell Lung Cancer},
journal = {JCO Clinical Cancer Informatics},
year = {2025},
doi = {10.1200/cci-24-00315}
}
EUVIMED